Anti-ERK5 antibody [EP791Y]
- RabMAb
- Recombinant
- KO Validated
- What is this?
5
(1 Review)
|
(20 Publications)
Rabbit Recombinant Monoclonal ERK5 antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human, Mouse, Rat samples. Cited in 20 publications.
View Alternative Names
BMK1, ERK5, PRKM7, MAPK7, Mitogen-activated protein kinase 7, MAP kinase 7, MAPK 7, Big MAP kinase 1, Extracellular signal-regulated kinase 5, BMK-1, ERK-5
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-ERK5 antibody [EP791Y] (AB40809)
Intracellular Flow Cytometry analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labeling ERK5 with purified ab40809 at 1/50 dilution (10 ug/ml) (red). Cells were fixed with 80% methanol. A Goat anti rabbit IgG (Alexa Fluorr®488) secondary antibody was used at 1/2000 dilution. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-ERK5 antibody [EP791Y] (AB40809)
Immunocytochemistry/ Immunofluorescence analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labeling ERK5 with Purified ab40809 at 1 : 100 (4.8 μg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1 : 200 (2.5 μg/ml). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1 : 1000 (2 μg/ml) dilution. DAPI nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-ERK5 antibody [EP791Y] (AB40809)
Overlay histogram showing A549 cells stained with unpurified ab40809 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab40809, 1/100 dilution) for 30 min at 22°C. The secondary antibody used was Alexa Fluor® 488 goat anti-rabbit IgG (H&L) (ab150077) at 1/2000 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >5,000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter.
- IP
Unknown
Immunoprecipitation - Anti-ERK5 antibody [EP791Y] (AB40809)
ab40809 (purified) at 1 : 30 dilution (2ug) immunoprecipitating ERK5 in HeLa whole cell lysate.
Lane 1 (input) : HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate 10ug
Lane 2 (+) : ab40809 & HeLa whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab40809 in HeLa whole cell lysate
For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366) was used for detection at 1 : 1000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-ERK5 antibody [EP791Y] (ab40809)
Predicted band size: 88 kDa
Observed band size: 115 kDa
false
- WB
Lab
Western blot - Anti-ERK5 antibody [EP791Y] (AB40809)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-ERK5 antibody [EP791Y] (ab40809) at 1/2000 dilution
Lane 1:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysates at 15 µg
Lane 2:
NIH/3T3 (Mouse embryonic fibroblast) whole cell lysates at 15 µg
Lane 3:
PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysates at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 88 kDa
Observed band size: 115 kDa
false
- WB
Unknown
Western blot - Anti-ERK5 antibody [EP791Y] (AB40809)
The predicted weight of 89 kDa is for the precursor version of human ERK5 protein. However, ab40809 detects endogenous levels of total Erk5 protein which appears around 115 kDa in SDS PAGE
All lanes:
Western blot - Anti-ERK5 antibody [EP791Y] (ab40809) at 1/5000 dilution
All lanes:
Hela cell lysate at 10 µg
Predicted band size: 88 kDa
Observed band size: 115 kDa
false
- WB
Lab
Western blot - Anti-ERK5 antibody [EP791Y] (AB40809)
Lane 1 : Wild-type HAP1 whole cell lysate (20 μg)
Lane 2 : MAPK7 (ERK5) knockout HAP1 whole cell lysate (20 μg)
Lane 3 : HeLa whole cell lysate (20 μg)
Lanes 1 - 3 : Merged signal (red and green). Green - ab40809 observed at 88 kDa. Red - loading control, ab9484, observed at 37 kDa.
Unpurified ab40809 was shown to specifically react with ERK5 in wild-type HAP1 cells as signal was lost in MAPK7 (ERK5) knockout cells. Wild-type and MAPK7 (ERK5) knockout samples were subjected to SDS-PAGE. Unpurified ab40809 and ab9484 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-ERK5 antibody [EP791Y] (ab40809)
Predicted band size: 88 kDa
false
- WB
Lab
Western blot - Anti-ERK5 antibody [EP791Y] (AB40809)
Lanes 1- 2 : Merged signal (red and green). Green - ab40809 observed at 115 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.
ab40809 was shown to react with ERK5 in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab265508 (knockout cell lysate ab258042) was used. Wild-type HeLa and MAPK7 knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab40809 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-ERK5 antibody [EP791Y] (ab40809) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
MAPK7 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human MAPK7 (ERK5) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-mapk7-erk5-knockout-hela-cell-line-ab265508'>ab265508</a>)
Predicted band size: 88 kDa
Observed band size: 115 kDa
false
- WB
Supplier Data
Western blot - Anti-ERK5 antibody [EP791Y] (AB40809)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, ab323508 was shown to bind specifically to ERK5 (phospho T733). Target of interest was observed at 115 kDa in treated wild-type HeLa cell lysates (lanes -2-4) with no signal observed at this size in treated ERK5 knockout cell line (lanes 6-8) (lanes 5-8, knockout cell line ab265508 / knockout cell lysate ab258042).
Lane 1-8 on the left : untreated membrane;
Lane 1-8 on the right : membrane treated with alkaline phosphatase.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
In Western blot, Anti-ERK5 antibody [EP791Y] - Total protein control (ab40809) staining at 1/1000 dilution.
All lanes:
Western blot - Anti-ERK5 (phospho T733) antibody [EPR28258-101] (<a href='/en-us/products/primary-antibodies/erk5-phospho-t733-antibody-epr28258-101-ab323508'>ab323508</a>) at 1/1000 dilution
Lane 1:
Untreated parental HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
Parental HeLa treated with 0.4M Sorbitol for 30min whole cell lysate at 20 µg
Lane 3:
Parental HeLa treated with 100nM Calyculin A for 30min whole cell lysate at 20 µg
Lane 4:
Parental HeLa treated with 0.4M Sorbitol and 100nM Calyculin A for 30min whole cell lysate at 20 µg
Lane 5:
Untreated ERK5 knockout HeLa whole cell lysate at 20 µg
Lane 6:
ERK5 knockout HeLa treated with 0.4M Sorbitol for 30min whole cell lysate at 20 µg
Lane 7:
ERK5 knockout HeLa treated with 100nM Calyculin A for 30min whole cell lysate at 20 µg
Lane 8:
ERK5 knockout HeLa treated with 0.4M Sorbitol and 100nM Calyculin A for 30min whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 115 kDa,36 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-ERK5 antibody [EP791Y] (AB40809)
Lane 1-4 on the left : untreated membrane;
Lane 1-4 on the right : membrane treated with alkaline phosphatase.
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, Anti-ERK5 antibody [EP791Y] - Total protein control (ab40809) staining at 1/1000 dilution.
All lanes:
Western blot - Anti-ERK5 (phospho T733) antibody [EPR28258-101] (<a href='/en-us/products/primary-antibodies/erk5-phospho-t733-antibody-epr28258-101-ab323508'>ab323508</a>) at 1/1000 dilution
Lane 1:
Untreated NIH/3T3 (mouse embryonic fibroblast) whole cell lysate at 20 µg
Lane 2:
NIH/3T3 treated with 0.4M Sorbitol for 30min whole cell lysate at 20 µg
Lane 3:
NIH/3T3 treated with 100nM Calyculin A for 30min whole cell lysate at 20 µg
Lane 4:
NIH/3T3 treated with 0.4M Sorbitol and 100nM Calyculin A for 30min whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 115 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-ERK5 antibody [EP791Y] (AB40809)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, Anti-6X His tag® antibody [EPR20547] - ChIP Grade (ab213204) staining at 1/5000 dilution.
In Western blot, Anti-ERK5 antibody [EP791Y] - Total protein control (ab40809) staining at 1/1000 dilution.
All lanes:
Western blot - Anti-ERK5 (phospho T733) antibody [EPR28258-101] (<a href='/en-us/products/primary-antibodies/erk5-phospho-t733-antibody-epr28258-101-ab323508'>ab323508</a>) at 1/1000 dilution
Lane 1:
293T (human embryonic kidney epithelial cell) cells co-transfected with a human ERK5 WT expression vector containing a myc-His-tag® and a rat MEK5(S311D/T315D mutation)) expression vector containing a myc-His-tag®, whole cell lysate at 10 µg
Lane 2:
293T (human embryonic kidney epithelial cell) cells co-transfected with a human ERK5 (T733A mutation) expression vector containing a myc-His-tag® and a rat MEK5(S311D/T315D mutation)) expression vector containing a myc-His-tag®, whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 115 kDa
false
Exposure time: 70s
Related conjugates and formulations (1)
-
Anti-ERK5 antibody [EP791Y] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ERK5 influences cellular functions through its role in promoting cell proliferation and differentiation. It serves as part of a signaling complex that includes the MAP kinase kinase 5 (MEK5). This interaction allows ERK5 to phosphorylate and subsequently activate target substrates such as transcription factors promoting cellular responses necessary for development and survival. ERK5 also plays a role in the response to oxidative stress which contributes to its impact on survival pathways and cellular stress responses.
Pathways
ERK5 acts within the MAPK signaling cascade and is linked to the ERK/MAPK pathway and the phosphoinositide 3-kinase (PI3K) pathway. Within these pathways ERK5 interacts with other MAP kinases and regulatory proteins such as Ras and Raf contributing to a wide range of cellular processes including growth migration and survival. Through these interactions ERK5 influences cellular dynamics and mediates responses to growth factors and stress stimuli.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (20)
Recent publications for all applications. Explore the full list and refine your search
European journal of medical research 30:117 PubMed39972514
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:1736 PubMed39966385
2025
Applications
Unspecified application
Species
Unspecified reactive species
FEBS open bio 12:1498-1508 PubMed35778889
2022
Applications
Unspecified application
Species
Unspecified reactive species
Diabetes, obesity & metabolism 24:1721-1733 PubMed35546452
2022
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 23:132 PubMed35069813
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of biochemical and molecular toxicology 36:e22981 PubMed34984768
2022
Applications
Unspecified application
Species
Unspecified reactive species
Immunity 54:1665-1682.e14 PubMed34129840
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 25:3803-3815 PubMed33621420
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of endocrinology 2020:8821077 PubMed33488706
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of trace elements in medicine and biology 61:126546 PubMed32480051
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com